Drugs in Development (The Pharm Voice)
In a June 15 entry, blogger Gloria Gamat writes about Arena Pharmaceuticals' drug candidate for obesity, lorcaserin hydrochloride, and the favorable Phase IIb clinical trial results it recently displayed.
Deception? (Drug Injury Watch)
Citing several articles from the Associated Press, blogger Tom Lamb discusses the issue of possible deceptive practices used in drug marketing.